💊2017 News Releases |Pharma Inc

By Soverign

💊2017 News Releases |Pharma Inc.

Astellas and Seattle Genetics Initiate Phase 1b Trial of Enfortumab Vedotin in Combination with Immune Checkpoint Inhibitor Therapies in Locally Advanced or Metastatic Urothelial Cancer

https://www.astellas.com/en/corporate/news/detail/astellas-and-seattle-genetics.html

Takeda Announces Positive Results from its Phase 3 Clinical Trial in Japan Evaluating the Efficacy and Safety of Relugolix in the Treatment of Pain Symptoms Associated with Uterine Fibroids

https://www.takeda.com/newsroom/newsreleases/2017/takeda-announces-positive-results-from-its-phase-3-clinical-trial-in-japan/

ONO announces collaboration with Neurimmune in Neurodegenerative Diseases Field

http://www.ono.co.jp/eng/news/pdf/sm_cn171109.pdf

 

More from tokioX :

  1. 📡Saudi Arabia – Terminal High Altitude Area Defense and Related Support, Equipment and Services
  2. Discovered a neural circuit distinguishing and conveying memory and exercise information.   20170905
  3. トヨタとマツダ、EVパートナーとして、16億米ドルで米国工場を計画
  4. 英国、2040年までに新ディーゼルとガソリン車の販売を禁止
  5. BAEシステム、Brimstoneミサイルの最初の実弾発射に成功
  6. 米国のSM-3ミサイルは、日本を北朝鮮から守ることができるか？  (  Can America’s SM-3 Missile Protect Japan from North Korea? ）防衛 SM-3 Missile
  7. New Delaware Chapter 11–TK Holdings, Inc. | TK Holdings, Inc., a subsidiary of Takata Corporation, and eleven (11) of its subsidiaries and affiliates have filed   −   タカタ株式会社の子会社・TKホールディングス株式会社及びその子会社及び関連会社11社は、第11章デラウェア州破産裁判所（訴訟第17-11375号）の救済訴訟を提起